- Home
- TLSI vs MCN Comparison
TLSI vs MCN Comparison
Compare TLSI & MCN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TLSI
- MCN
- Stock Information
- Founded
- TLSI 2010
- MCN 2004
- Country
- TLSI United States
- MCN Canada
- Employees
- TLSI N/A
- MCN N/A
- Industry
- TLSI Medical Specialities
- MCN
- Sector
- TLSI Health Care
- MCN
- Exchange
- TLSI Nasdaq
- MCN Nasdaq
- Market Cap
- TLSI 124.9M
- MCN 149.1M
- IPO Year
- TLSI N/A
- MCN N/A
- Fundamental
- Price
- TLSI $3.95
- MCN $6.80
- Analyst Decision
- TLSI Strong Buy
- MCN
- Analyst Count
- TLSI 6
- MCN 0
- Target Price
- TLSI $11.75
- MCN N/A
- AVG Volume (30 Days)
- TLSI 52.7K
- MCN 52.9K
- Earning Date
- TLSI 11-14-2024
- MCN 01-01-0001
- Dividend Yield
- TLSI N/A
- MCN 9.96%
- EPS Growth
- TLSI N/A
- MCN N/A
- EPS
- TLSI N/A
- MCN N/A
- Revenue
- TLSI $26,891,000.00
- MCN N/A
- Revenue This Year
- TLSI $60.97
- MCN N/A
- Revenue Next Year
- TLSI $53.69
- MCN N/A
- P/E Ratio
- TLSI N/A
- MCN N/A
- Revenue Growth
- TLSI 67.90
- MCN N/A
- 52 Week Low
- TLSI $3.50
- MCN $6.69
- 52 Week High
- TLSI $10.42
- MCN $8.60
- Technical
- Relative Strength Index (RSI)
- TLSI 46.18
- MCN 30.40
- Support Level
- TLSI $3.76
- MCN $6.72
- Resistance Level
- TLSI $4.17
- MCN $7.04
- Average True Range (ATR)
- TLSI 0.35
- MCN 0.06
- MACD
- TLSI -0.04
- MCN -0.03
- Stochastic Oscillator
- TLSI 33.66
- MCN 24.39
About TLSI TriSalus Life Sciences Inc.
TriSalus Life Sciences Inc is engaged in the research, development, and sales of innovative drug delivery technology and immune-oncology therapeutics to improve outcomes in difficult-to-treat liver and pancreatic cancer. It is developing and marketing two product lines Pressure Enabled Drug Delivery (PEDD) infusion systems, in use today, and an investigational agent, nelitolimod (SD-101), which shows potential to enhance immune system response in the treatment of hepatocellular cancer, pancreatic cancer and other liver solid tumors. TriNav is the newest therapy delivery device with SmartValve technology for the proprietary PEDD approach.
About MCN Madison Covered Call & Equity Strategy Fund
Madison Covrd Call & Eqt Strtg Fd is a diversified, closed-end management investment company. The primary objective is to provide a high level of current income and current gains. Its secondary objective is to achieve long-term capital appreciation. The fund seeks to achieve its objectives by investing in large and mid-capitalization common stocks. Its portfolio of investments consists of different sectors investment such as consumer discretionary, consumer staples, energy, financials, healthcare, industrials, information technology, materials, real estate, utilities, exchange-traded funds, U.S. government and agency obligations, and money market funds.